by Laurie Ann Coring | Dec 5, 2023 | News
LSNS Member in the News DECEMBER 4, 2023 — HALIFAX, Nova Scotia–3D BioFibR Inc. (“3D BioFibR”), a leading innovator in the field of tissue engineering and regenerative medicine, today announced that it has appointed Michael Francis, Ph.D., to its Board of...
by Shana Cristoferi | Mar 18, 2020 | IMV Inc., News
See original release here FOR IMMEDIATE RELEASE Dartmouth, Nova Scotia, March 18, 2020 – IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company (the “Company” or “IMV”), today announced that it is advancing the clinical development of a DPX-based...
by Shana Cristoferi | Feb 29, 2020 | News
See original HUDDLE article here HALIFAX—Dr. Brendan Carr, the president and CEO of the Nova Scotia Health Authority, admits the province’s health care system faces some challenging problems. Emergency room closures, doctor recruitment, high cancer rates, and a host...
by Shana Cristoferi | Feb 28, 2020 | BF2030, News
For Immediate Release: Atlantic Canadian Medtech Companies Invited to Pitch for $100K at Five-Part Health Challenge Events HALIFAX, NS (February 28, 2020) – To further drive innovation in the health ecosystem, the Nova Scotia Health Authority, BioNova, the Atlantic...
by Shana Cristoferi | Feb 25, 2020 | IMV Inc., News
See original release here February 25, 2020 at 3:05 AM EST First in-vivo T cell therapy to demonstrate clinical activity in hard-to-treat solid tumor 79% of evaluable patients achieved disease control on target lesions; 53% experienced tumor regressions 37% achieved...
